Buscar
Mostrando ítems 61-70 de 7024
Molecular modeling databases: A new way in the search of protein targets for drug development
(2007-01-01)
DBMODELING is a relational database of annotated comparative protein structure models and their metabolic, pathway characterization. It is focused on enzymes identified in the genomes of Mycobacterium tuberculosis and ...
Molecular modeling databases: A new way in the search of protein targets for drug development
(2007-01-01)
DBMODELING is a relational database of annotated comparative protein structure models and their metabolic, pathway characterization. It is focused on enzymes identified in the genomes of Mycobacterium tuberculosis and ...
Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment
There is little or no research initiated on enlightening Nigerians about the pathogenesis, targets for
drug development, and drug repositioning for SARS
-CoV
-2 infection. COVID
-19 is a viral infection
causing symptoms ...
Potential molecular targets for antituberculosis drug discoveryPotenciais alvos moleculares para o desenvolvimento de novos fÁrmacos antituberculose
(2017-06-01)
Tuberculosis (TB) is an infectious disease caused by mycobacteria from the Mycobacterium genus, mainly by Mycobacterium tuberculosis (MTB). The World Health Organization (WHO) aims to reduce the number of TB cases worldwide ...
In silico structural characterization of protein targets for drug development against Trypanosoma cruzi
(Springer Verlag (Germany), 2017)
Review on the occurrence and biological effects of illicit drugs in aquatic ecosystems
(Springer, 2020-05-02)
Illicit drugs (IDs) and their metabolites are recognized as contaminants of emerging concern. After consumption, illicit drugs are partially metabolized and excreted unchanged in urine and feces or as active metabolites ...
Purposely engineered drug-target mismatches for entropy-based drug optimization
(Elsevier Science London, 2012-01)
Proteins are dynamic objects, often undergoing significant structural change and reducing their conformational possibilities upon binding to a ligand. Thus, unless dynamic information is incorporated, structure-based drug ...
Trypanosoma cruzi targets for new chemotherapeutic approaches
(Taylor & Francis, 2019)